Privacy policy

Last updated November 22, 2020
Thank you for choosing to be part of our community at EYE-GO A/S (“Company“, “we“, “us“, “our“). We are committed to protecting your personal information and your right to privacy. If you have any questions or concerns about this privacy notice, or our practices with regards to your personal information, please contact us at
When you visit our website (the “Website“), and more generally, use any of our services (the “Services“, which include the Website), we appreciate that you are trusting us with your personal information. We take your privacy very seriously. In this privacy notice, we seek to explain to you in the clearest way possible what information we collect, how we use it and what rights you have in relation to it. We hope you take some time to read through it carefully, as it is important. If there are any terms in this privacy notice that you do not agree with, please discontinue use of our Services immediately.
This privacy notice applies to all information collected through our Services (which, as described above, includes our Website), as well as, any related services, sales, marketing or events.
Please read this privacy notice carefully as it will help you understand what we do with the information that we collect.

Information automatically collected
In Short: Some information — such as your Internet Protocol (IP) address and/or browser and device characteristics — is collected automatically when you visit our Website.
We automatically collect certain information when you visit, use or navigate the Website. This information does not reveal your specific identity (like your name or contact information) but may include device and usage information, such as your IP address, browser and device characteristics, operating system, language preferences, referring URLs, device name, country, location, information about how and when you use our Website and other technical information. This information is primarily needed to maintain the security and operation of our Website, and for our internal analytics and reporting purposes.
Like many businesses, we also collect information through cookies and similar technologies.
The information we collect includes:
  • Log and Usage Data. Log and usage data is service-related, diagnostic, usage and performance information our servers automatically collect when you access or use our Website and which we record in log files. Depending on how you interact with us, this log data may include your IP address, device information, browser type and settings and information about your activity in the Website (such as the date/time stamps associated with your usage, pages and files viewed, searches and other actions you take such as which features you use), device event information (such as system activity, error reports (sometimes called ‘crash dumps’) and hardware settings).
  • Device Data. We collect device data such as information about your computer, phone, tablet or other device you use to access the Website. Depending on the device used, this device data may include information such as your IP address (or proxy server), device and application identification numbers, location, browser type, hardware model Internet service provider and/or mobile carrier, operating system and system configuration information.
  • Location Data. We collect location data such as information about your device’s location, which can be either precise or imprecise. How much information we collect depends on the type and settings of the device you use to access the Website. For example, we may use GPS and other technologies to collect geolocation data that tells us your current location (based on your IP address). You can opt out of allowing us to collect this information either by refusing access to the information or by disabling your Location setting on your device. Note however, if you choose to opt out, you may not be able to use certain aspects of the Services.
In Short: We process your information for purposes based on legitimate business interests, the fulfillment of our contract with you, compliance with our legal obligations, and/or your consent.
We use personal information collected via our Website for a variety of business purposes described below. We process your personal information for these purposes in reliance on our legitimate business interests, in order to enter into or perform a contract with you, with your consent, and/or for compliance with our legal obligations. We indicate the specific processing grounds we rely on next to each purpose listed below.

We use the information we collect or receive:

  • To send administrative information to you. We may use your personal information to send you product, service and new feature information and/or information about changes to our terms, conditions, and policies.
  • To protect our Services. We may use your information as part of our efforts to keep our Website safe and secure (for example, for fraud monitoring and prevention).
  • To enforce our terms, conditions and policies for business purposes, to comply with legal and regulatory requirements or in connection with our contract.
  • To respond to legal requests and prevent harm. If we receive a subpoena or other legal request, we may need to inspect the data we hold to determine how to respond.
  • To send you marketing and promotional communications. We and/or our third-party marketing partners may use the personal information you send to us for our marketing purposes, if this is in accordance with your marketing preferences. For example, when expressing an interest in obtaining information about us or our Website, subscribing to marketing or otherwise contacting us, we will collect personal information from you. You can opt-out of our marketing emails at any time (see the “WHAT ARE YOUR PRIVACY RIGHTS” below).
  • Deliver targeted advertising to you. We may use your information to develop and display personalized content and advertising (and work with third parties who do so) tailored to your interests and/or location and to measure its effectiveness.
  • For other business purposes. We may use your information for other business purposes, such as data analysis, identifying usage trends, determining the effectiveness of our promotional campaigns and to evaluate and improve our Website, products, marketing and your experience. We may use and store this information in aggregated and anonymized form so that it is not associated with individual end users and does not include personal information. We will not use identifiable personal information without your consent.
In Short: We only share information with your consent, to comply with laws, to provide you with services, to protect your rights, or to fulfill business obligations.
We may process or share your data that we hold based on the following legal basis:
  • Consent: We may process your data if you have given us specific consent to use your personal information for a specific purpose.
  • Legitimate Interests: We may process your data when it is reasonably necessary to achieve our legitimate business interests.
  • Performance of a Contract: Where we have entered into a contract with you, we may process your personal information to fulfill the terms of our contract.
  • Legal Obligations: We may disclose your information where we are legally required to do so in order to comply with applicable law, governmental requests, a judicial proceeding, court order, or legal process, such as in response to a court order or a subpoena (including in response to public authorities to meet national security or law enforcement requirements).
  • Vital Interests: We may disclose your information where we believe it is necessary to investigate, prevent, or take action regarding potential violations of our policies, suspected fraud, situations involving potential threats to the safety of any person and illegal activities, or as evidence in litigation in which we are involved.
More specifically, we may need to process your data or share your personal information in the following situations:
  • Business Transfers. We may share or transfer your information in connection with, or during negotiations of, any merger, sale of company assets, financing, or acquisition of all or a portion of our business to another company.
In Short: We may use cookies and other tracking technologies to collect and store your information.
We may use cookies and similar tracking technologies (like web beacons and pixels) to access or store information. Specific information about how we use such technologies and how you can refuse certain cookies is set out in our Cookie Notice.
In Short: We may transfer, store, and process your information in countries other than your own.
Our servers are located in. If you are accessing our Website from outside, please be aware that your information may be transferred to, stored, and processed by us in our facilities and by those third parties with whom we may share your personal information (see “WILL YOUR INFORMATION BE SHARED WITH ANYONE?” above), in and other countries.
If you are a resident in the European Economic Area, then these countries may not necessarily have data protection laws or other similar laws as comprehensive as those in your country. We will however take all necessary measures to protect your personal information in accordance with this privacy notice and applicable law.
In Short: We keep your information for as long as necessary to fulfill the purposes outlined in this privacy notice unless otherwise required by law.
We will only keep your personal information for as long as it is necessary for the purposes set out in this privacy notice, unless a longer retention period is required or permitted by law (such as tax, accounting or other legal requirements). No purpose in this notice will require us keeping your personal information for longer than 90 days.
When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize such information, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
In Short: We aim to protect your personal information through a system of organizational and technical security measures.
We have implemented appropriate technical and organizational security measures designed to protect the security of any personal information we process. However, despite our safeguards and efforts to secure your information, no electronic transmission over the Internet or information storage technology can be guaranteed to be 100% secure, so we cannot promise or guarantee that hackers, cybercriminals, or other unauthorized third parties will not be able to defeat our security, and improperly collect, access, steal, or modify your information. Although we will do our best to protect your personal information, transmission of personal information to and from our Website is at your own risk. You should only access the Website within a secure environment.
In Short: We do not knowingly collect data from or market to children under 18 years of age.
We do not knowingly solicit data from or market to children under 18 years of age. By using the Website, you represent that you are at least 18 or that you are the parent or guardian of such a minor and consent to such minor dependent’s use of the Website. If we learn that personal information from users less than 18 years of age has been collected, we will deactivate the account and take reasonable measures to promptly delete such data from our records. If you become aware of any data we may have collected from children under age 18, please contact us at
In Short: You may review, change, or terminate your account at any time.
If you are a resident in the European Economic Area and you believe we are unlawfully processing your personal information, you also have the right to complain to your local data protection supervisory authority. You can find their contact details here:
If you are a resident in Switzerland, the contact details for the data protection authorities are available here:
Cookies and similar technologies: Most Web browsers are set to accept cookies by default. If you prefer, you can usually choose to set your browser to remove cookies and to reject cookies. If you choose to remove cookies or reject cookies, this could affect certain features or services of our Website. To opt-out of interest-based advertising by advertisers on our Website visit
Most web browsers and some mobile operating systems and mobile applications include a Do-Not-Track (“DNT”) feature or setting you can activate to signal your privacy preference not to have data about your online browsing activities monitored and collected. At this stage no uniform technology standard for recognizing and implementing DNT signals has been finalized. As such, we do not currently respond to DNT browser signals or any other mechanism that automatically communicates your choice not to be tracked online. If a standard for online tracking is adopted that we must follow in the future, we will inform you about that practice in a revised version of this privacy notice.
In Short: Yes, if you are a resident of California, you are granted specific rights regarding access to your personal information.
California Civil Code Section 1798.83, also known as the “Shine The Light” law, permits our users who are California residents to request and obtain from us, once a year and free of charge, information about categories of personal information (if any) we disclosed to third parties for direct marketing purposes and the names and addresses of all third parties with which we shared personal information in the immediately preceding calendar year. If you are a California resident and would like to make such a request, please submit your request in writing to us using the contact information provided below.
If you are under 18 years of age, reside in California, and have a registered account with the Website, you have the right to request removal of unwanted data that you publicly post on the Website. To request removal of such data, please contact us using the contact information provided below, and include the email address associated with your account and a statement that you reside in California. We will make sure the data is not publicly displayed on the Website, but please be aware that the data may not be completely or comprehensively removed from all our systems (e.g. backups, etc.).
In Short: Yes, we will update this notice as necessary to stay compliant with relevant laws.
We may update this privacy notice from time to time. The updated version will be indicated by an updated “Revised” date and the updated version will be effective as soon as it is accessible. If we make material changes to this privacy notice, we may notify you either by prominently posting a notice of such changes or by directly sending you a notification. We encourage you to review this privacy notice frequently to be informed of how we are protecting your information.
If you have questions or comments about this notice, you may email us at
Based on the applicable laws of your country, you may have the right to request access to the personal information we collect from you, change that information, or delete it in some circumstances. To request to review, update, or delete your personal information, please submit a request form by clicking here. We will respond to your request within 30 days.
March 2023

New team member

We are happy to share that we’ve welcomed Signe Wej Jensen to our team as RA/QA Engineer.


Signe has experience from the Danish medical device companies Ambu and Radiometer Medical, where she has worked mainly with support to development projects, risk management, supplier management, sterilization validation, auditing and handling of complaints and nonconformities.


Welcome to Signe!

March 2023

MistGo® article in ONdrugDelivery

“MistGo® is designed with the user in mind to ensure successful instillation every time”


In the latest issue of the ONdrugDelivery magazine, EYE-GO discuss the benefits of MistGo® – EYE-GO’s microdosing eye medication delivery system for chronic ophthalmic diseases such as dry eye disease and glaucoma.


Read the article here

Download the full issue here (pp 18-22)

Get in touch

Morten Nielsen
Morten is a senior executive with strong experience in strategic business transformations and strategy execution. He has a background as Partner with PA Consulting Group and has held CEO and other executive positions specializing in Drug Delivery Devices and Connected Health. Morten additionally operates as a MedTech Mentor.

January 2023

EYE-GO receives soft funding!

We are extremely grateful to announce that EYE-GO has been funded from not only one but two sources.


Thank you to:

Innovation Fund Denmark’s Innobooster program enabling start-up companies develop and mature new products with economic and societal potential.


Lighthouse Life Science aiming to map Denmark as a lighthouse the world looks towards for innovative life science technologies.

The funding will help EYE-GO further develop MistGo® – EYE-GOs micro-dosing eye medication delivery system – and prepare for an effective high-volume production.



December 2022

EYE-GO receives scholarship

EYE-GO is the proud receiver of a scholarship from the Danish Sportsgoodsfond.

The Sportsgoodsfond has awarded 3 start-ups having distinguished themselves by developing useful technologies improving human lives and benefiting society.


“Everyone on our team believes in what we are working on, and we know that our solution will be able to improve the quality of life for many people in the world. The prize will help us make a difference for people who are affected by chronic eye diseases – and sight is one of the most important senses we have” said Christian Bent Rode, CFO in EYE-GO A/S when receiving the scholarship on behalf of EYE-GO.


Congratulations to the other two award-wining companies ZenzeTech and GO-Pen.



June 2022

More assets added to our team

We’re excited to share that we’ve welcomed two new colleagues: Henrik Sandberg, joining our team as Senior Project Engineer and Mark Poulsen joining our team as Principal Process Engineer.
Henrik has worked in development of medical equipment 30+ years with a focus on research and process development of medical equipment specializing in quality relations between device and manufacturing processes. Henrik will help integrate process development into product development to achieve efficient manufacturing processes and accelerate time to market. Henrik comes from similar positions at the Danish companies Radiometer Medical and Novo Nordisk.

Mark is specialized within polymer welding processes and design for manufacturing and assembly. Mark will take part in ensuring a robust volume manufacturing of MisGo® that involves: Maturing design and processes, specifying machinery, running in machinery, validation and ramp-up.  Mark comes from similar positions at the Danish companies Novo Nordisk and Coloplast where he has been involved in several development project of devices that are now volume manufactured both in- and outside of Denmark.

We’re pleased to have added additional asset like Henrik and Mark to our team.

April 2022

Stronger EYE-GO team

To accelerate our development activities even further, Morten Jacobsen has joined our team as Senior Project Manager. Morten has a strong track record within R&D project management and comes from a similar position with the Danish medical device company Ambu.

We’re pleased to have added an asset like Morten to our team.

April 2022

New funding secured

EYE-GO is excited to announce that we have raised more than USD 1M in a new investment round. The investment has been secured with the participation of all current shareholders comprising business angles and Maj Invest Holding.

The capital raised enables us to move towards the next product development milestone verifying the delivery system MistGo®.

April 2022

Strengthening of the board

Martin Laub and Erik Stener Jørgensen have been appointed as new EYE-GO board members. Martin and Erik are active members in and chairs of a list of boards within various industries including the life science industry.

Martin has solid commercial background and important entrepreneurial know-how from many years as business angel. Erik is a Statutory Auditor and has since 1992 worked as partner with Grant Thornton since 2011 merged with PWC.

Morten Nielsen
Board Member
Morten joined EYE-GO as board member in 2022. He is a senior executive with strong experience in strategic business transformations and strategy execution. Morten has a background as Partner with PA Consulting Group and has held CEO and other executive positions specializing in Drug Delivery Devices and Connected Health. Morten operates as a MedTech Mentor and holds several board positions.

Kim Tosti
Board Member

Kim joined EYE-GO as board member in 2023. Kim has extensive experience in the pharmaceutical industry as advisor and as former senior executive at Novo Nordisk, specializing in drug and device manufacturing and commercial contracts. Over the years, Kim has actively invested in, studied, and provided support to numerous tech/AI startups. By combining his extensive knowledge in big pharma, start-ups, and AI, Kim has been instrumental in supporting achieving results.

February 2022

Danish Business Award

EYE-GO is proud to receive the Business Award 2021 from the Municipality of Rudersdal in Denmark. EYE-GO is awarded for entrepreneurship with great growth potential.


Press release from Rudersdal Municipality:

“EYE-GO is an entrepreneurial company with a revolutionizing innovation and a great potential. EYE-GO has developed the eye care technology MistGo®, which can replace traditional eye care bottles and improve the quality of life for people suffering from eye conditions.”


Henrik Nagel, CEO of EYE-GO, states: “EYE-GO has a dream to improve the quality of life of people worldwide suffering from chronic eye conditions. We believe MistGo® can disrupt the way people take their eye-medication. No more hassle with eye drop bottles, which are often difficult and uncomfortable to use, and which lead to over-medication – simply because of the size of the liquid drop. MistGo® is easy and comfortable to use and only dispenses the precise dose absorbable by the eye in a gentle mist quicker than you can blink. With this, we make it easier to follow a treatment plan to the benefit of patients, practitioners and the society.”


EYE-GO is a start-up company located at DTU Science Park close to Copenhagen with a functional prototype tested by professionals and users. In the near future EYE-GO will add to the team to speed up the product development and identify pharma partners to go to market.

September 1st 2021

Strong preference for mist delivery

During the summer, EYE-GO teamed up with the Department of Ophthalmology at the University Hospital in Copenhagen to conduct a Comfort study of the MistGo® technology. 20 patients aged 40-90 years and suffering from dry eye disease with severe to mild symptoms participated. The results were striking and univocal. The study confirmed a strong preference of patients for our mist delivery over drop delivery from an eye drop bottle.


Commonly cited reasons for high scores in favor of the mist delivery with MistGo® were:

“I feel the liquid is distributed better and more effectively in the eye with the mist.”
“My eyes feel better lubricated with the mist.”
“The mist leaves no excess liquid in my face or running down my cheeks.”
“The mist dose seems more optimal and therefore also more economic.”
“With the mist delivery I have peace of mind and feel reassured that my eyes have been treated correctly”.


To learn more about the study and scores, contact Henrik Nagel on

May 1st 2021

Touch and test the real thing

EYE-GO is happy to announce that we have developed
the first fully functional prototype of MistGo®. This milestone achievement is in line with the technical development project.


It means that partners can now touch and feel the right thing and even test MistGo® on the skin with a simple saline solution.


Contact Henrik Nagel on for more.

December 14th 2020.
Global press release

Disrupting eye treatment

Danish MedTech start-up disrupts the global market for eye treatment: Many challenges are associated with the conventional eye drop bottle. The global ophthalmic industry has long pushed for a way to better deliver medication to the eye. Now, the Danish-based MedTech start-up, EYE-GO, has the solution that can improve the lives of millions of people globally suffering from severe eye conditions. Leading ophthalmologists and frontrunning international players in the industry have already named it “a true game-changer in eye treatment”. The Danish state participated in the latest investment round.

EYE-GO has developed a truly revolutionary medical device for ophthalmic drug administration. This system is the first to consistently secure the right dose and the right delivery into the cornea of the eye so that people with severe and chronic eye conditions can benefit from the full effect of the ocular medication for improved eye health.

Henrik Nagel, CEO of EYE-GO elaborates: “One of the disruptive features of our technology is a high precision micro pump that releases a gentle mist of only 6µl (microliters), which matches the optimal absorption capacity of the cornea. In comparison, a dense drop from an eye drop bottle is between 30-60µl (microliters), which is a significant waste of resources as it cannot be absorbed in the cornea, and also risks irritating the skin around the eyes.”

The effectiveness of EYE-GO’s advanced technology makes it cost-competitive globally to the conventional eye drop bottle. It further allows the global ophthalmic industry to optimize the level of active ingredients and introduce innovative ocular medication for entirely new treatment possibilities. That is good news for patients, and for business.

Another revolutionary aspect of EYE-GO’s ocular drug delivery system is its ease of use.

Henrik explains: “We wanted to create an exceptional user experience, at the same time as delivering the best therapeutic treatment effect for the eye. The result is a system that is extremely easy and comfortable to use – whether you are young or senior, and whether you are at home or on the go. People with eye disease are simply much more inclined to complete their treatment when it can be done in a convenient, comfortable, and hassle-free way. And that translates directly into a reduced risk of blindness, improved eye health, and quality of life.”

Chairman of the board, Christian Stig Møller concludes: “We are very excited about the future. From the beginning, there has been an overwhelming interest in EYE-GO, and we are far in the dialogue with several interested pharma partners. We are also in the very fortunate position that all funding is in place to finalize the fully functional prototype that is reproducible in large numbers. That will take us from proof of technology to proof of concept.” Today, the circle of owners of EYE-GO includes business angles, Maj Invest, and as of this fall also financial support from Vækstfonden and Innovationsfonden, both owned by the Danish state. 

December 2020

New funding secured 

EYE-GO is excited to announce that we have raised more than USD 1 million in a new investment round. The investment has been secured with the participation of all current shareholders that comprise business angles and Maj Invest, but also from Vækstfonden and Innovationsfonden – both owned by the Danish state.


This capital injection enables us to produce our first fully functional prototype that is reproduceable in large numbers, thus moving us from proof of technology to proof of concept.

November 2020

New RA & QA Director on board

Our team is growing again. To secure a strategic approach to RA and QA as well as handle the dialogue with relevant regulatory bodies going forward, Sten Elkjær Andersen will join our team as Director of RA & QA also as of November 1st.


Sten has worked within the medico industry his entire professional career amongst others as Director of RA & QA at Ambu A/S. With Sten on board we are equipped best possible to continue to comply with and develop in line with regulatory requirements.

Christian Stig Møller
Chairman of the Board
Christian joined EYE-GO as chairman of the board in 2018. He is one of the leading financers in Denmark focused on non-listed investments. At present Christian is partner in Nordic Bloom. For the past 20 years Christian has been CEO in several mid-large size companies in Denmark and abroad including Bank of Copenhagen.

Christian also holds the position as Chairman of the Board in several other start-ups and investment funds.

Jacob Dyhr Jensen
Board Member
Jacob joined EYE-GO as board member in 2023. He has a financial background and currently holds a position as Investment Manager with Maj Invest Equity where he has been employed since 2014. Further, he previously spent time at the life sciences department of the Consulate General of Denmark in New York where he, among other, facilitated contact between American investors and Danish biotech and pharma companies. Jacob brings solid experience when it comes to commercial strategy, financing and M&A.

October 2018

New Chairman and CEO 

In an effort to secure greater strategic focus and even better execution of the strategy, it has been decided to make changes in key organizational positions at EYE-GO. As of October 2018, chairman Jesper Boysen and board member Henrik E. Wulff will step out of the board. Instead former board member Christian Stig Møller has been constituted as new chairman. 


At the same time, the new board of directors has decided to appoint Henrik Nagel as new CEO of EYE-GO. Henrik comes with more than 25 years of international management experience from world-leading tech companies mainly within life science. He is the perfect candidate to secure the future continued success of EYE-GO.  

October 2020

Our team is growing

To further strengthen our commercial muscle and accelerate activities even further Louise von Haffner will join our team as Director of Business Development as of October 1st. With her strong track record of translating tech solutions into compelling value propositions and of bringing wining go2market strategies to life, we are certain Louise will be a great asset to our team.


At the same time we staff-up in the area of RA and QA. To secure a strategic approach to RA and QA as well as handle the dialogue with relevant regulatory bodies going forward, Sten Elkjær Andersen will join our team as Director of RA & QA also as of October 1st. Sten has worked within the medico industry his entire professional career amongst others as Director of RA & QA at Ambu A/S. With Sten on board we are equipped best possible to continue to comply with and develop in line with regulatory requirements